Skip to main content

Cidara Therapeutics, Inc.

CDTXDelisted Jan 7, 2026
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001610618

Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.

13F holders, Q3 2025

Institutional positions in Cidara Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
173
+64 vs. Q2 2025
Shares held
32.5M
+6.58M (+25.4%) vs. Q2 2025
Total value
$3.11B
+$1.85B (+146.4%) vs. Q2 2025
New holders
77
51 more added
Sold out
13
30 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 173 institutions
Q1 2021: 62 institutionsQ2 2021: 55 institutionsQ3 2021: 50 institutionsQ4 2021: 53 institutionsQ1 2022: 44 institutionsQ2 2022: 46 institutionsQ3 2022: 42 institutionsQ4 2022: 42 institutionsQ1 2023: 54 institutionsQ2 2023: 52 institutionsQ3 2023: 52 institutionsQ4 2023: 51 institutionsQ1 2024: 50 institutionsQ2 2024: 26 institutionsQ3 2024: 27 institutionsQ4 2024: 40 institutionsQ1 2025: 46 institutionsQ2 2025: 109 institutionsQ3 2025: 173 institutionsQ4 2025: 255 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2025: $3.11B
Q1 2021: $56.6MQ2 2021: $40.5MQ3 2021: $42.1MQ4 2021: $39.5MQ1 2022: $25.2MQ2 2022: $13.3MQ3 2022: $17.1MQ4 2022: $20.2MQ1 2023: $34.4MQ2 2023: $29.7MQ3 2023: $22.7MQ4 2023: $18.4MQ1 2024: $20.3MQ2 2024: $16.9MQ3 2024: $35.6MQ4 2024: $183.6MQ1 2025: $205.9MQ2 2025: $1.26BQ3 2025: $3.11BQ4 2025: $7.36BQ1 2026: $0Q2 2026: $0
Institutions holding CDTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 2025255$7.36B
Q3 2025173$3.11B
Q2 2025109$1.26B
Q1 202546$205.9M
Q4 202440$183.6M
Q3 202427$35.6M
Q2 202426$16.9M
Q1 202450$20.3M
Q4 202351$18.4M
Q3 202352$22.7M
Q2 202352$29.7M
Q1 202354$34.4M
Q4 202242$20.2M
Q3 202242$17.1M
Q2 202246$13.3M
Q1 202244$25.2M
Q4 202153$39.5M
Q3 202150$42.1M
Q2 202155$40.5M
Q1 202162$56.6M

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q2 2025.

Institutions holding CDTX in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
SEI Investments Co50,525$4.84M0.01%+44,272+708.0%Added
Wasatch Advisors Inc51,310$4.91M0.03%+51,310New
Royal Bank of Canada52,381$5.02M0.00%+21,114+67.5%Added
Catalio Capital Management, LP53,333$5.11M0.94%+53,333New
Sofinnova Investments, Inc.54,197$5.19M0.32%−196,834−78.4%Reduced
Resolute Capital Asset Partners LLC57,315$5.49M2.87%+30,000+109.8%Added
Ameriprise Financial Inc58,486$5.60M0.00%+12,437+27.0%Added
Eventide Asset Management, LLC61,081$5.85M0.10%+61,081New
AXA Investment Managers S.A.61,154$5.86M0.02%+61,154New
Wellington Management Group LLP65,895$6.31M0.00%+65,895New
Superstring Capital Management LP68,463$6.56M6.46%+68,463New
HighVista Strategies LLC70,904$6.79M1.66%+70,904New
Sphera Funds Management Ltd.75,743$7.25M1.72%−62,258−45.1%Reduced
EAM Investors, LLC79,012$7.47M0.86%+9,110+13.0%Added
Octagon Capital Advisors LP100,000$9.58M1.50%+100,000New
Boothbay Fund Management, LLC101,864$9.75M0.25%−55,962−35.5%Reduced
Renaissance Technologies LLC104,260$9.98M0.01%−52,517−33.5%Reduced
Velan Capital Investment Management LP108,404$10.4M9.75%+8,404+8.4%Added
Lord, Abbett & Co. LLC109,704$10.5M0.03%+109,704New
Barclays PLC113,379$10.9M0.00%+83,755+282.7%Added
Russell Investments Group, Ltd.116,293$11.1M0.01%+116,293New
Patient Square Capital LP121,000$11.6M3.10%+106,000+706.7%Added
Summit Partners Public Asset Management, LLC130,000$12.4M0.41%+130,000New
Susquehanna International Group, LLP133,511$12.8M0.02%+78,671+143.5%Added
J. Goldman & Co LP138,091$13.2M0.50%+138,091New
Acuta Capital Partners, LLC141,529$13.6M14.01%−38,040−21.2%Reduced
Charles Schwab Investment Management Inc145,418$13.9M0.00%+95,986+194.2%Added
Northern Trust Corp150,168$14.4M0.00%+4,997+3.4%Added
StemPoint Capital LP152,325$14.6M2.94%−114,449−42.9%Reduced
Invesco Ltd.157,172$15.1M0.00%+31,746+25.3%Added
Atika Capital Management LLC157,320$15.1M1.28%+157,320New
Standard Life Aberdeen plc177,523$17.0M0.03%−82,393−31.7%Reduced
Millennium Management LLC188,283$18.0M0.01%+188,283New
Balyasny Asset Management LLC197,560$18.9M0.04%+80,361+68.6%Added
Driehaus Capital Management LLC216,219$20.7M0.15%−6,220−2.8%Reduced
Silverarc Capital Management, LLC220,902$21.2M3.06%+116,959+112.5%Added
Baker Bros. Advisors LP227,272$21.8M0.16%00.0%Unchanged
Marshall Wace, LLP235,310$22.5M0.02%−7,469−3.1%Reduced
Bank of America Corp241,771$23.2M0.00%+196,446+433.4%Added
Rock Springs Capital Management LP249,402$23.9M1.40%+115,269+85.9%Added
Goldman Sachs Group Inc270,004$25.9M0.00%+265,289+5,626.5%Added
Ikarian Capital, LLC277,704$26.6M6.03%−186,784−40.2%Reduced
First Light Asset Management, LLC292,657$28.0M2.64%+112,042+62.0%Added
Deep Track Capital, LP300,000$28.7M0.80%+50,000+20.0%Added
Samlyn Capital, LLC307,960$29.5M0.42%+307,960New
Jefferies Financial Group Inc.365,000$35.0M0.32%−85,000−18.9%Reduced
Logos Global Management LP375,000$35.9M3.55%+185,000+97.4%Added
Morgan Stanley378,184$36.2M0.00%−505,231−57.2%Reduced
Jennison Associates LLC396,015$37.9M0.02%+346,803+704.7%Added
Vestal Point Capital, LP400,000$38.3M1.74%−100,000−20.0%Reduced
Geode Capital Management, LLC404,114$38.7M0.00%+32,104+8.6%Added
Maverick Capital LtdSuperinvestorMaverick Capital417,550$40.0M0.54%+417,550New
Adage Capital Partners GP, L.L.C.450,000$43.1M0.07%−650,000−59.1%Reduced
UBS Group AG473,554$45.3M0.01%+295,644+166.2%Added
Holocene Advisors, LP487,233$46.7M0.11%+487,233New
Soleus Capital Management, L.P.493,811$47.3M2.53%+31,000+6.7%Added
Fred Alger Management, LLC502,877$48.2M0.19%+502,877New
Farallon Capital Management, L.L.C.508,000$48.6M0.27%+308,000+154.0%Added
Commodore Capital LP585,000$56.0M2.73%−590,000−50.2%Reduced
Citadel Advisors LLC593,993$56.9M0.05%+303,042+104.2%Added
Janus Henderson Group PLC682,901$65.4M0.03%+57,901+9.3%Added
State Street Corp772,759$74.0M0.00%+535,822+226.1%Added
FMR LLC775,533$74.3M0.00%+666,815+613.3%Added
VR Adviser, LLC946,788$90.7M5.10%+307,700+48.1%Added
Paradigm Biocapital Advisors LP961,164$92.0M2.72%+961,164New
Darwin Global Management, Ltd.997,196$95.0M2.64%+228,772+29.8%Added
BlackRock, Inc.1,165,453$111.6M0.00%+57,785+5.2%Added
Vanguard Group Inc1,230,666$117.8M0.00%+263,961+27.3%Added
Vivo Capital, LLC1,311,425$125.6M10.11%00.0%Unchanged
BVF Inc1,414,165$135.4M5.49%+627,773+79.8%Added
Point72 Asset Management, L.P.1,578,069$151.1M0.33%+50,139+3.3%Added
Bain Capital Life Sciences Investors, LLC3,020,990$289.3M19.20%+520,310+20.8%Added
Ra Capital Management, L.P.3,365,523$322.3M3.97%00.0%Unchanged
TCG Crossover Management, LLC0$00.00%−1,005,901−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−63,223−100.0%Sold out
AXA S.A.0$00.00%−61,154−100.0%Sold out
Ghisallo Capital Management LLC0$00.00%−25,000−100.0%Sold out
American Century Companies Inc0$00.00%−16,221−100.0%Sold out
SummitTX Capital, L.P.0$00.00%−9,197−100.0%Sold out
XTX Topco Ltd0$00.00%−8,512−100.0%Sold out
Walleye Capital LLC0$00.00%−5,900−100.0%Sold out
Clark Wealth Partners0$00.00%−105−100.0%Sold out
Aster Capital Management (DIFC) Ltd0$00.00%−57−100.0%Sold out
Dauntless Investment Group, LLC0$00.00%−54−100.0%Sold out
SBI Securities Co., Ltd.0$00.00%−9−100.0%Sold out
Twin Peaks Wealth Advisors, LLC0$00.00%−1−100.0%Sold out